Alcohol consumption and the incidence of Parkinson's disease

Annals of Neurology

Volumn 54, Issue 2, 2003, Pages 170-175

  Hernán, Miguel A ^a   Chen, Honglei ^a   Schwarzschild, Michael A ^b   Ascherio, Alberto ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CAFFEINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; BEER; CIGARETTE SMOKING; COFFEE; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FUTUROLOGY; HABIT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; WINE;

ADULT; AGED; ALCOHOL DRINKING; BEER; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POPULATION; RISK ASSESSMENT; SEX FACTORS; SMOKING; WINE;

EID: 0041843796     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10611     Document Type: Article

References (43)

1. Hernán MA, Takkouche B, Caamaño-Isorna F, Gestal-Otero J. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 2002;52:276-284.
2. Morens DM, Grandinetti A, Reed D, et al. Cigarette smoking and protection from Parkinson's disease. Neurology 1995;45:1041-1051.
3. Ascherio A, Zhang SM, Hernán MA, et al. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 2001;50:56-63.
4. Chen J, Xu K, Petzer J, et al. Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci 2001;21:RC143.
5. Schwarzschild MA, Chen JF, Ascherio A. Caffeinated clues and the promise of adenosine A(2A) antagonists in PD. Neurology 2002;58:1154-1160.
6. Paulson GW, Dadmehr N. Is there a premorbid personality typical for Parkinson's disease? Neurology 1991;41(suppl 2):73-76.
7. Menza M. The personality associated with Parkinson's disease. Curr Psychiatry Rep 2000;2:421-426.
8. Grandinetti A, Morens DM, Reed D, MacEachern D. Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol 1994;139:1129-1138.
9. Willems-Giesbergen PCLM, de Rijk MC, van Switen JC, et al. Smoking, alcohol, and coffee consumption and the risk of PD: results from the Rotterdam Study. Neurology 2000;54(suppl 3):A347-A348.
10. Paganini-Hill A. Risk factors for Parkinson's disease: the Leisure World Cohort Study. Neuroepidemiology 2001;20:118-124.
11. Haack DG, Baumann RJ, McKean HE, et al. Nicotine exposure and Parkinson's disease. Am J Epidemiol 1981;114:191-200.
12. Godwin-Austen RB, Lee PN, Marmot MG, Stern GM. Smoking and Parkinson's disease. J Neurol Neurosurg Psychiatry 1982;45:577-581.
13. Ngim CH, Devathasan G. Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease. Neuroepidemiology 1989;8:128-141.
14. Ho S, Woo J, Lee CM. Epidemiologic study of Parkinson's disease in Hong Kong. Neurology 1989;39:1314-1318.
15. Jiménez-Jiménez FJ, Mateo D, Giménez-Roldán S. Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: a case-control study. Mov Disord 1992;7:339-344.
16. Wang W-z, Fang X-h, Cheng X-m, et al. A case-control study on the environmental risk factors of Parkinson's disease in Tianjin, China. Neuroepidemiology 1993;12:209-218.
17. Mayeux R, Tang MX, Marder K, et al. Smoking and Parkinson's disease. Mov Disord 1994;9:207-212.
18. Morano A, Jiménez-Jiménez FJ, Molina JA, Antolín MA. Risk factors for Parkinson's disease: case-control study in the province of Cáceres, Spain. Acta Neurol Scand 1994;89:164-170.
19. Hellenbrand W, Seidler A, Boeing H, et al. Diet and Parkinson's disease I: a possible role for the past intake of specific foods and food groups. Results from a self-administered food frequency questionnaire in a case-control study. Neurology 1996;47:636-643.
20. Liou HH, Tsai MC, Chen CJ, et al. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 1997;48:1583-1588.
21. Smargiassi A, Murti A, De Rosa A, et al. A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna Region of Italy. Neurotoxicology 1998;19:709-712.
22. Fall PA, Fredrikson M, Axelson O, Granérus AK. Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord 1999;14:28-37.
23. Gorell JM, Rybicki A, Johnson CC, Peterson EL. Smoking and Parkinson's disease: a dose-response relationship. Neurology 1999;52:115-119.
24. Benedetti MD, Bower JH, Maraganore DM, et al. Smoking, alcohol, and coffee consumption preceding Parkinson's disease. Neurology 2000;55:1350-1358.
25. Behari M, Srivastava AK, Das RR, Pandey RM. Risk factors of Parkinson's disease in Indian patients. J Neurol Sci 2001;190:49-55.
26. Checkoway H, Powers K, Smith-Weller T, et al. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 2002;155:732-738.
27. Hernán MA, Zhang SM, Rueda-deCastro AM, et al. Cigarette smoking and the incidence of Parkinson's disease in two prospective studies. Ann Neurol 2001;50:780-786.
28. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122:51-65.
29. Giovannucci E, Colditz G, Stampfer M, et al. The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol 1991;133:810-817.
30. Rimm EB, Giovanucci EL, Stampfer MJ, et al. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114-1126.
31. Hu FB, Stampfer MJ, Rimm E, et al. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 1999;149:531-540.
32. Carr LA, Rowell PP. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke. Neuropharmacology 1990;29:311-314.
33. Ryan RE, Ross SA, Drago J, Loiacono RE. Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha-4 nicotinic receptor subunit knockout mice. Br J Pharmacol 2001;132:1650-1656.
34. Castagnoli KP, Steyn SJ, Petzer JP, et al. Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco. Chem Res Toxicol 2001;14:523-527.
35. Corsini GU, Zuddas A, Bonuccelli U, et al. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde. Life Sci 1987;40:827-832.
36. Zuddas A, Corsini GU, Schinelli S, et al. MPTP treatment combined with ethanol or acetaldehyde selectively destroys dopaminergic neurons in mouse substantia nigra. Brain Res 1989;501:1-10.
37. Ghiselli A, Natella F, Guidi A, et al. Beer increases plasma antioxidant capacity in humans. J Nutr Biochem 2000;11:76-80.
38. Nishioka K, Sumida T, Iwatani M, et al. Influence of moderate drinking and purine and carbohydrate metabolism. Alcohol Clin Exp Res 2002;26:20S-25S.
39. Yamamoto T, Moriwaki Y, Takahashi S, et al. Effect of beer on the plasma concentrations of uridine and purine bases. Metabolism 2002;51:1317-1323.
40. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981;78:6858-6862.
41. Jones DC, Gunasekar PG, Borowitz JL, Isom GE. Dopamine-induced apoptosis is mediated by oxidative stress and is enhanced by cyanide in differentiated PC12 cells. J Neurochem 2000;74:2296-2304.
42. Duan W, Ladenheim B, Cutler RG, et al. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J Neurochem 2002;80:101-110.
43. Davis JW, Grandinetti A, Waslien CI, et al. Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease. Am J Epidemiol 1996;144:480-484.